Switzerland, Denmark, UK, and Ireland are not obvious choices — but the data says otherwise. AstraZeneca and GSK alone make the UK a top-tier pharma destination.
The UK is frequently underrated in pharma. AstraZeneca (Cambridge) is the world's second most valuable pharma company; GSK (London) is in the global top 10. Both run large graduate programmes. Ireland is similarly underrated: it produces more pharmaceuticals by value per capita than any other country, driven by Pfizer, Johnson & Johnson, AbbVie, and Amgen manufacturing campuses. For non-EU graduates, Ireland's General Employment Permit is accessible. Denmark's relevance is almost entirely Novo Nordisk — but that one company's GLP-1 dominance has created thousands of high-quality graduate positions in Bagsværd and Kalundborg.
See exactly which countries give you the best shot at these companies — scored, ranked, and sourced.